Publications
29
Citations
1,689
Est. group size
~6
Recurring co-author estimate
Active years
19
Publishing since 2007
Johanna M. Schafer's work spans several areas of cancer biology, including how tumor cells acquire abnormal chromosome numbers (aneuploidy) and how this relates to mutated p53 function, how ubiquitin-related enzymes (proteins that tag other proteins for degradation) work, and clinical testing of biomarkers like HER2 in bladder cancer. The research combines laboratory studies of cell signaling and protein biochemistry with more clinically oriented work on diagnostic testing methods in cancer patients.
Publication output has been steady to slightly increasing over the past decade, with a notable peak in 2022 and continued activity through 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Testing and Interpretation of Human Epidermal Growth Factor Receptor 2 Protein Expression and <i>ERBB2</i> Gene Amplification in Advanced Urothelial Carcinoma
JCO Precision Oncology · 2025
- Optimized isolation of enzymatically active ubiquitin E3 ligase E6AP/UBE3A from mammalian cells
Protein Expression and Purification · 2025
- Systematic literature review and testing of HER2 status in urothelial carcinoma (UC).
Journal of Clinical Oncology · 2023
- Redefining the catalytic HECT domain boundaries for the HECT E3 ubiquitin ligase family
Bioscience Reports · 2022
- Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes
Nature Communications · 2021
- Abstract 2489: A functional genomics approach to determine mutant p53 gain-of-function mechanisms and phenotypes in tumorigenesis
Cancer Research · 2021
- Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors
Science Translational Medicine · 2020
- Tyramide Signal-Amplified Immunofluorescence of MYCN and MYC in Human Tissue Specimens and Cell Line Cultures
BIO-PROTOCOL · 2020
- Membrane capacitance recordings resolve dynamics and complexity of receptor-mediated endocytosis in Wnt signalling
Scientific Reports · 2019
- Membrane capacitance recordings resolve dynamics and complexity of receptor-mediated endocytosis in Wnt signalling
bioRxiv (Cold Spring Harbor Laboratory) · 2018
- Abstract 531: Activity of the selective FGFR 1, 2 and 3 inhibitor INCB054828 in genetically-defined models of triple-negative breast cancer
Cancer Research · 2017
- Abstract 1518: Mechanisms of bromodomain and extra-terminal motif inhibitor (BETi) sensitivity in triple-negative breast cancer (TNBC)
Cancer Research · 2017
- Cancer Research×3
- Nature×2
- Science Immunology×1
- Science Translational Medicine×1
- Nature Communications×1
- Amir Mortazavi
Medicine · The Ohio State University
- Shang-Jui Wang
Medicine · The Ohio State University
- Danielle Elise Zimmerman
Medicine · The Ohio State University
- Hristos Z. Kaimakliotis
Medicine · Indiana University
- Ming Yin
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile